COMPANY
Hope Pharmaceuticals
NIH awards 4
- NIH award 5R44NS063485-03 FY2011: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SHERMAN, CRAIG; recipient as written: HOPE PHARMACEUTICALS, SCOTTSDALE, AZ. Prevention of Delayed Cerebral Vasospasm source ↗
- NIH award 1R43HL103035-01 FY2010: $236,917 awarded for that fiscal year; activity R43 (SBIR); PI SHERMAN, CRAIG; recipient as written: HOPE PHARMACEUTICALS, SCOTTSDALE, AZ. Prevention of ischemia reperfusion injury a source ↗
- NIH award 5R44NS063485-02 FY2010: $799,507 awarded for that fiscal year; activity R44 (SBIR); PI SHERMAN, CRAIG; recipient as written: HOPE PHARMACEUTICALS, SCOTTSDALE, AZ. Prevention of Delayed Cerebral Vasospasm As source ↗
- NIH award 1R44NS063485-01 FY2009: $100,000 awarded for that fiscal year; activity R44 (SBIR); PI SHERMAN, CRAIG; recipient as written: HOPE PHARMACEUTICALS, SCOTTSDALE, AZ. Prevention of Delayed Cerebral Vasospasm As source ↗